lilly oral glp 1 Medscape | Orforglipron, Eli Lilly's investigational glucagon-like peptide receptor agonist (GLP-1 RA), achieved positive phase 3 results for Orforglipron: Eli Lilly's New Oral
Description
Weight loss: By increasing satiety and reducing food intake, as well as slowing gastric emptying, GLP-1s help reduce body weight (which further helps metabolic health)
Cranberry Hydration Elixir: Refreshing cranberry with a little cayenne and ginger kick
doi: 10.6061/clinics/2016(01)08
They help make you feel fuller all day long and prevent you from overeating
Bode, J
